Measuring uncertainty in complex decision analysis models
暂无分享,去创建一个
[1] G. Chapman,et al. Decision Making in Health Care: Theory, Psychology, and Applications , 2003 .
[2] A H Briggs,et al. A Bayesian approach to stochastic cost-effectiveness analysis. , 1999, Health economics.
[3] A J Moskowitz,et al. Bayesian estimation of cost-effectiveness ratios from clinical trials. , 1999, Health economics.
[4] M C Weinstein,et al. Use and misuse of the term "cost effective" in medicine. , 1986, The New England journal of medicine.
[5] Frank A. Sloan,et al. Valuing health care , 1996 .
[6] B. McNeil,et al. Probabilistic Sensitivity Analysis Using Monte Carlo Simulation , 1985, Medical decision making : an international journal of the Society for Medical Decision Making.
[7] A. Detsky,et al. Evidence-based medicine. A new approach to teaching the practice of medicine. , 1992, JAMA.
[8] Eric R. Ziegel,et al. Modeling in Medical Decision Making , 2002, Technometrics.
[9] Peter Green,et al. Markov chain Monte Carlo in Practice , 1996 .
[10] K Claxton,et al. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. , 1999, Journal of health economics.
[11] G. DeFriese,et al. The Stroke Prevention Patient Outcomes Research Team: Goals and Methods , 1993, Stroke.
[12] P. Wakker,et al. Confidence intervals for cost/effectiveness ratios. , 1995, Health economics.
[13] M. Degroot. Optimal Statistical Decisions , 1970 .
[14] G. Torrance. A generalized cost-effectiveness model for the evaluation of health programs , 1970 .
[15] Robert M. Kaplan. Valuing health care: Utility assessment for estimating quality-adjusted life years , 1995 .
[16] E Laska,et al. Statistical methods for cost-effectiveness analyses. , 1996, Controlled clinical trials.
[17] A O'Hagan,et al. A framework for cost-effectiveness analysis from clinical trial data. , 2001, Health economics.
[18] Peter C. Fishburn,et al. Utility theory for decision making , 1970 .
[19] K. Manton,et al. Chronic Disease Modelling: Measurement and Evaluation of the Risks of Chronic Disease Processes , 1988 .
[20] J Lipscomb,et al. Performing cost-effectiveness analysis by integrating randomized trial data with a comprehensive decision model: application to treatment of acute ischemic stroke. , 1999, Journal of clinical epidemiology.
[21] M. Gold. Cost-effectiveness in health and medicine , 2016 .
[22] J Lipscomb,et al. Assessing Uncertainty in Cost-Effectiveness Analyses , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.
[23] A. O'Hagan,et al. Probabilistic sensitivity analysis of complex models: a Bayesian approach , 2004 .
[24] S. Thompson,et al. How should cost data in pragmatic randomised trials be analysed? , 2000, BMJ : British Medical Journal.
[25] M J Al,et al. Costs, effects and C/E-ratios alongside a clinical trial. , 1994, Health economics.
[26] D. Sackett,et al. Evidence based medicine: what it is and what it isn't , 1996, BMJ.
[27] K E Willard,et al. Probabilistic Analysis of Decision Trees Using Monte Carlo Simulation , 1986, Medical decision making : an international journal of the Society for Medical Decision Making.
[28] Giovanni Parmigiani,et al. On Optimal Screening Ages , 1993 .
[29] M. Weinstein,et al. Theoretical issues in cost-effectiveness analysis. , 1997, Journal of health economics.
[30] Simon Thompson,et al. Statistical issues in cost-effectiveness analyses. , 2002, Statistical methods in medical research.
[31] A O'Hagan,et al. Bayesian cost‐effectiveness analysis from clinical trial data , 2001, Statistics in medicine.
[32] L. Goldman,et al. Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model. , 1987, American journal of public health.
[33] John B. Kidd,et al. Decisions with Multiple Objectives—Preferences and Value Tradeoffs , 1977 .
[34] Howard Raiffa,et al. Applied Statistical Decision Theory. , 1961 .
[35] David Draper,et al. Assessment and Propagation of Model Uncertainty , 2011 .
[36] Anthony O'Hagan,et al. The probability of cost-effectiveness , 2002, BMC medical research methodology.
[37] A A Stinnett,et al. Net Health Benefits , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.
[38] Marek Ancukiewicz,et al. Decision Models in Clinical Recommendations Development : the Stroke Prevention Policy , 1996 .
[39] Frank A. Sloan,et al. Valuing health care : costs, benefits, and effectiveness of pharmaceuticals and other medical technologies , 1995 .
[40] Giovanni Parmigiani,et al. The Stroke Prevention Policy Model: Linking Evidence and Clinical Decisions , 1997, Annals of Internal Medicine.
[41] Joseph S. Pliskin,et al. Utility Functions for Life Years and Health Status , 1980, Oper. Res..
[42] Gregory K. Miller,et al. Elements of Applied Stochastic Processes , 1972 .